(S)-(-)-去甲乌药碱氢溴酸盐
|
|
|
- CAS号:
- 105990-27-0
- 英文名:
- (S)-(-)-HigenaMine HydrobroMide
- 英文别名:
- Coclaurine Impurity 16;(-)-Higenamine hydrobromide;(S)-(-)-HigenaMine HydrobroMide;(S)-(-)-Norcoclaurine hydrobromide;(1S)-1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol:hydrobromide;(1S)-1,2,3,4-Tetrahydro-1-[(4-hydroxyphenyl)methyl]-6,7-isoquinolinediol hydrobromide (1:1)
- 中文名:
- (S)-(-)-去甲乌药碱氢溴酸盐
- 中文别名:
- 乌药碱杂质16;(S)-(-)-去甲乌药碱氢溴酸盐
- CBNumber:
- CB42694623
- 分子式:
- C16H18BrNO3
- 分子量:
- 352.22302
- MOL File:
- 105990-27-0.mol
|
|
|
(S)-(-)-去甲乌药碱氢溴酸盐化学性质
-
熔点:
-
>250°C (dec.)
-
|
-
储存条件:
-
Hygroscopic, -20°C Freezer, Under inert atmosphere
-
|
-
溶解度:
-
DMSO (Slightly), Methanol (Slightly)
-
|
-
形态:
-
Solid
-
|
-
颜色:
-
Off-White to Beige
-
|
-
稳定性:
-
Hygroscopic
-
|
(S)-(-)-去甲乌药碱氢溴酸盐性质、用途与生产工艺
(S)-Higenamine ((S)-Norcoclaurine) hydrobromide，Higenamine 的 S 型异构体，是苄基异喹啉生物碱生物合成的起始化合物，由去甲月桂碱合酶 (NCS) 将多巴胺和 4-羟基苯乙醛 (4-HPAA) 缩合生成。
|
Human Endogenous Metabolite
|
The biosynthetic pathway leading to benzylisoquinoline alkaloids originates from the enzyme-catalyzed condensation of dopamine and 4-hydrophenylacetaldehyde to yield (S)-norcoclaurine. Both substrates are secondary metabolites derived from the decarboxylation/hydroxylation/deamination of tyrosine.
(S)-(-)-去甲乌药碱氢溴酸盐
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/04/30 | HY-N2037C | (S)-(-)-去甲乌药碱氢溴酸盐
(S)-Higenamine hydrobromide | 105990-27-0 | 1mg | 3450元 |
105990-27-0, (S)-(-)-去甲乌药碱氢溴酸盐 相关搜索:
- Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals
- C16H17NO3HBr
- 乌药碱杂质16
- (S)-(-)-去甲乌药碱氢溴酸盐
- 105990-27-0
- Coclaurine Impurity 16
- (1S)-1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol:hydrobromide
- (-)-Higenamine hydrobromide
- (S)-(-)-Norcoclaurine hydrobromide
- (1S)-1,2,3,4-Tetrahydro-1-[(4-hydroxyphenyl)methyl]-6,7-isoquinolinediol hydrobromide (1:1)
- (S)-(-)-HigenaMine HydrobroMide